drugset
drugset / Trial / NCT02077140

A Study of MDT-10013 in the Treatment of Acute Postoperative Pain Following Bunionectomy

NCT02077140 ↗

Phase 2 Completed 192 enrolled Medtronic Spinal and Biologics
RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this study is to evaluate the efficacy and safety of MDT-10013 in men and women 18 to 80 years of age who are undergoing bunionectomy. The primary objective is to determine the analgesic efficacy of MDT-10013 compared with standard of care in the treatment of acute postoperative pain after subjects undergo bunionectomy.

Timeline

Start
2014-02
Primary completion
2015-11
Completion
2016-02

Drugs

EvaluationDrugModalityDoseRoute
Subject MDT-10013 Unknown — —

Indications

No indication recorded.